US Patent 9849169 MDR
Patent 9849169 was granted and assigned to Arsanis on December, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits on 2 Oct, 2024
Golden AI
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+387 characters)
Article
Patent abstract
The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Adriana Badarau0
Eszter Nagy0
Gerhild Zauner0
Gábor Nagy0
Irina Mirkina0
Jolanta Lukasiewicz0
Luis Guachalla0
Valéria Szijárto0
Zoltán Magyarics0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09849169 MDR US Patent 9849169 MDR
Infobox
Patent Number
098491690
Patent Number
98491690
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
098491690
Date of Patent
December 26, 2017
0Patent Application Number
146511560
Date Filed
January 17, 2014
0Patent Primary Examiner
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09849169 MDR
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09849169
Date of patent
December 26, 2017
Patent application number
14651156
Date Filed
January 17, 2014
Patent primary examiner
Find more entities like US Patent 9849169 MDR
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
